- Corporate Officers - M
- Maddaluna Anthony J
Insider Trading History of Maddaluna Anthony J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Maddaluna Anthony J since 2013.
The trader's CIK number is 1566333.
At the time of the last reporting, Maddaluna Anthony J was the Executive Vice President of Intec Pharma Ltd.. (stock ticker symbol NTEC).
Also see all insider trading activities at Intec Pharma Ltd..
Note that in the past
MADDALUNA ANTHONY J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Intec Pharma Ltd. (NTEC) by Maddaluna Anthony J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | NTEC | 25,000 | $11,750 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pfizer Inc (PFE) by Maddaluna Anthony J
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | PFE | 0 | $0 | 18,950 | $632,062 | 94,998 | $1,864,782 |
2015 | PFE | 0 | $0 | 18,000 | $617,715 | 50,416 | $905,241 |
2014 | PFE | 0 | $0 | 8,925 | $279,683 | 29,695 | $377,126 |
2013 | PFE | 0 | $0 | 154,500 | $4,837,760 | 155,408 | $3,984,670 |
Insider trading activities at 2 companies by Maddaluna Anthony J:
1. Intec Pharma Ltd. (NTEC)
2. Pfizer Inc (PFE)
Table 1. Insider trading of Intec Pharma Ltd. (NTEC) by Maddaluna Anthony J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-08-27 | NTEC | Buy | 25,000 | .47 | 11,750 |
Table 2. Insider trading of Pfizer Inc (PFE) by Maddaluna Anthony J
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-11-09 | PFE | Sale | 10,000 | 33.00 | 330,000 |
2016-11-02 | PFE | Option Ex | 32,545 | 21.03 | 684,421 |
2016-05-09 | PFE | Sale | 8,950 | 33.75 | 302,062 |
2016-02-24 | PFE | Option Ex | 62,453 | 18.90 | 1,180,361 |
2015-02-25 | PFE | Option Ex | 23,649 | 17.69 | 418,350 |
2015-02-12 | PFE | Sale | 9,000 | 34.85 | 313,695 |
2015-02-10 | PFE | Sale | 9,000 | 33.78 | 304,020 |
2014-12-31 | PFE | Option Ex | 26,767 | 18.19 | 486,891 |
2014-12-08 | PFE | Sale | 6,500 | 32.00 | 208,000 |
2014-10-29 | PFE | Sale | 2,425 | 29.56 | 71,683 |
2014-02-26 | PFE | Option Ex | 29,695 | 12.70 | 377,126 |
2013-11-14 | PFE | Option Ex | 92,000 | 26.20 | 2,410,400 |
2013-11-14 | PFE | Sale | 92,000 | 32.10 | 2,953,200 |
2013-11-01 | PFE | Option Ex | 43,500 | 25.87 | 1,125,345 |
2013-11-01 | PFE | Sale | 43,500 | 31.03 | 1,349,805 |
2013-03-08 | PFE | Sale | 19,000 | 28.14 | 534,755 |
2013-02-28 | PFE | Option Ex | 19,908 | 22.55 | 448,925 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Maddaluna Anthony J
(Executive Vice President of Intec Pharma Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.